Evidence map›Paper›PMID 21784156›Full record

ArticleNeurobiology of disease2011

Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorder.

E R Bychkov, M R Ahmed, V V Gurevich, J L Benovic, E V Gurevich

Open access · greenAbstract readComparative Study
In one paragraph

Article in Neurobiology of disease, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Multiple functions of G protein-coupled receptor kinases.Journal of molecular signaling · 2014
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

E R BychkovDepartment of Pharmacology, Vanderbilt University, Nashville, TN, USA.
M R Ahmed
V V Gurevich
J L Benovic
E V Gurevich
Vanderbilt University · USThomas Jefferson University · US

Funding

White Matter Abnormalities in SchizophreniaP50MH066392 · NIMH · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI O'DONOVAN, MICHAEL J · 2002 to 2012
$18.6M
A Natonal Resource for Postmortem Brain ResearchR24MH068855 · NIMH · MC LEAN HOSPITAL (BELMONT, MA) · PI BENES, FRANCINE M. · 2003 to 2012
$14.8M
Role of Arrestins in G Protein-Coupled Receptor RegulationR37GM047417 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI BENOVIC, JEFFREY L · 2006 to 2015
$4.3M
Arrestin interactions with non-receptor binding partnersR01GM077561 · NIGMS · VANDERBILT UNIVERSITY · PI GUREVICH, VSEVOLOD V. · 2007 to 2015
$2.3M
ARRESTINS IN G PROTEIN-COUPLE RECEPTOR REGULATIONR01GM047417 · NIGMS · THOMAS JEFFERSON UNIVERSITY · PI BENOVIC, JEFFREY L · 1994 to 2005
$1.8M
Signaling regulation in the striatum in Parkinson's diseaseR01NS065868 · NINDS · VANDERBILT UNIVERSITY · PI GUREVICH, EUGENIA V · 2009 to 2013
$1.7M
Dopamine Receptor Trafficking in Parkinson's DiseaseR01NS045117 · NINDS · VANDERBILT UNIVERSITY · PI GUREVICH, EUGENIA V · 2003 to 2007
$1.6M
NIGMS NIH HHS GM47417NIGMS NIH HHS GM77561NIGMS NIH HHS R01 GM047417NIGMS NIH HHS R01 GM077561NIGMS NIH HHS R37 GM047417NIMH NIH HHS MH066392NIMH NIH HHS MH068855NIMH NIH HHS P50 MH066392NIMH NIH HHS R24 MH068855NINDS NIH HHS NS045117NINDS NIH HHS NS065868NINDS NIH HHS R01 NS045117NINDS NIH HHS R01 NS065868
6 · The paper itself

Abstract

Alterations of multiple G protein-mediated signaling pathways are detected in schizophrenia. G protein-coupled receptor kinases (GRKs) and arrestins terminate signaling by G protein-coupled receptors exerting a powerful influence on receptor functions. Modifications of arrestin and/or GRKs expression may contribute to schizophrenia pathology. Cortical expression of arrestins and GRKs was measured postmortem in control and subjects with schizophrenia or schizoaffective disorder. Additionally, arrestin/GRK expression was determined in elderly patients with schizophrenia and age-matched control. Patients with schizophrenia, but not schizoaffective disorder, displayed a reduced concentration of arrestin and GRK mRNAs and GRK3 protein. Arrestins and GRK significantly decreased with age. In elderly patients, GRK6 was reduced, with other GRKs and arrestins unchanged. A reduced cortical concentration of GRKs in schizophrenia (resembling that in aging) may result in altered G protein-dependent signaling, thus contributing to prefrontal deficits in schizophrenia. The data suggest distinct molecular mechanisms underlying schizophrenia and schizoaffective disorder.

Indexed as

AdultAgedAged, 80 and overArrestinsCohort StudiesFemaleG-Protein-Coupled Receptor Kinase 2G-Protein-Coupled Receptor Kinase 3G-Protein-Coupled Receptor Kinase 5G-Protein-Coupled Receptor KinasesHumansMaleMiddle AgedPrefrontal CortexPsychotic DisordersSchizophreniaArrestinsG-Protein-Coupled Receptor Kinase 2G-Protein-Coupled Receptor Kinase 3G-Protein-Coupled Receptor Kinase 5G-protein-coupled receptor kinase 6G-Protein-Coupled Receptor KinasesGRK2 protein, humanGRK3 protein, humanGRK5 protein, human

Identifiers

PMID21784156
PMCPMC3166984
OpenAlexW2036928931

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.